Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPGet Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Down 1.4%

NYSE:RVP opened at $0.75 on Wednesday. The company has a market capitalization of $22.46 million, a P/E ratio of -1.39 and a beta of 1.65. The stock’s 50 day moving average price is $0.72 and its 200 day moving average price is $0.72. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a 52 week low of $0.56 and a 52 week high of $1.22.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Retractable Technologies stock. Renaissance Technologies LLC raised its stake in shares of Retractable Technologies, Inc. (NYSE:RVPFree Report) by 9.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 361,253 shares of the company’s stock after buying an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.